Concepedia

Second malignancies following adjuvant chemotherapy:6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment ofnode-positive breast cancer patients

Chantal Bernard-Marty, Max S. Mano, Marianne Paesmans, Caterina Accettura, R. Munoz-Bermeo, Thomas J. Richard, K. Kleiber, Fátima Cardoso, J.P. Lobelle, Denis Larsimont,

Annals of Oncology · 2003 · 46 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al. · British Journal of Haematology · 1976 · 5.6K citations

, , +16

Polychemotherapy for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 2K citations

, , +7

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa et al. · New England Journal of Medicine · 1976 · 1.3K citations

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

Bernard Fisher, Ann Brown, N V Dimitrov et al. · Journal of Clinical Oncology · 1990 · 627 citations

, , +15

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 622 citations